The pharmaceutical glass packaging market is expected to grow at a CAGR of 9.7% during the forecast period of 2023 to 2031, driven by several key factors, including an expanding pharmaceutical sector, increasing demand for specialized packaging, and the rise of biological drugs.pharmaceutical glass packaging marketplays a pivotal role in the pharmaceutical industry, providing safe and reliable containers for drug storage and delivery. In conclusion, the pharmaceutical glass packaging market is set for substantial growth from 2023 to 2031, driven by an expanding pharmaceutical sector, increased demand for specialized packaging, and the prominence of biological drugs. Despite environmental sustainability concerns, the market's overall outlook is promising, with specific product segments, regions, and key players contributing to its trajectory.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
This product will be delivered within 2 business days.
Expanding Pharmaceutical Sector
The expansion of the pharmaceutical sector is a major driver of the pharmaceutical glass packaging market. As the global population continues to grow and age, there is an ever-increasing demand for pharmaceutical products. This growth is fueled by factors such as rising healthcare awareness, the prevalence of chronic diseases, and the emergence of new medical treatments. In 2022, the pharmaceutical sector witnessed substantial growth, boosting the demand for glass packaging products, including vials, bottles, cartridges & syringes, and ampoules.Increasing Demand for Specialized Packaging
The pharmaceutical glass packaging market is experiencing an increased demand for specialized packaging solutions. Pharmaceutical products are diverse, ranging from liquid injectables to solid oral medications, each requiring unique packaging requirements. Glass containers are favored for their inert and non-reactive properties, making them ideal for storing and preserving a wide range of pharmaceutical formulations. In 2022, the market responded to the demand for specialized packaging by offering a variety of products tailored to different drug types and administration methods.Rise of Biologic Drugs
The rise of biologic drugs is a significant driver of the pharmaceutical glass packaging market. Biologic drugs, including monoclonal antibodies, vaccines, and gene therapies, have gained prominence in recent years due to their effectiveness in treating complex diseases. These drugs often require specialized packaging to maintain their stability and efficacy. Glass containers have emerged as the preferred choice for packaging biological drugs because they offer a secure and sterile environment. In 2022, the market witnessed a surge in demand for glass packaging solutions to accommodate the growing production of biologics.Restraint - Environmental Sustainability
While the pharmaceutical glass packaging market shows significant promise, it faces a notable restraint concerning environmental sustainability. The production and disposal of glass packaging can have environmental implications, including energy consumption and waste generation. As environmental concerns gain momentum globally, pharmaceutical companies and regulatory bodies are increasingly emphasizing sustainable packaging solutions. This has led to the exploration of alternative materials and eco-friendly packaging options. Market players must address these sustainability challenges by investing in research and development to create more environmentally friendly glass packaging, optimize manufacturing processes, and explore recycling and reuse initiatives to reduce their environmental footprint.Market Segmentation by Product (Vials, Bottles, Cartridges & Syringes, Ampoules): The Vials segment Dominates the Market
The pharmaceutical glass packaging market offers a diverse range of products, each tailored to specific pharmaceutical packaging needs.- Vials: Vials are versatile containers widely used in the pharmaceutical industry for the storage of liquid and solid formulations. In 2022, the Vials segment dominated the market, driven by its suitability for various drug types and applications. Vials are expected to continue leading the market both in revenue and CAGR from 2023 to 2031, reflecting their adaptability and critical role in pharmaceutical packaging.
- Bottles: Pharmaceutical bottles are commonly used for packaging oral medications, syrups, and solutions. In 2022, the Bottles segment made a significant contribution to the market's revenue, catering to the demand for solid oral dosage forms and liquid formulations. While the growth rate is steady, bottles are expected to maintain their importance throughout the forecast period.
- Cartridges & Syringes: Cartridges and syringes play a vital role in drug delivery, especially for injectable formulations. This segment witnessed substantial growth in 2022, driven by the increasing use of prefilled syringes and auto-injectors. The Cartridges and syringes segment is expected to maintain the highest CAGR during the forecast period, reflecting the growing demand for specialized drug delivery systems.
- Ampoules: Ampoules are sealed vials used primarily for the storage of sensitive and sterile pharmaceuticals, including biologics and vaccines. In 2022, the Ampoules segment gained prominence, driven by the rise of biologic drugs. This segment is projected to exhibit the highest CAGR from 2023 to 2031, emphasizing its critical role in preserving and delivering complex pharmaceutical formulations.
Market Segmentation by Drug Type (Generic, Branded, Biologic): Generic drugs Dominates the Market
pharmaceutical glass packaging caters to various drug types, each with unique packaging requirements.- Generic Drugs: Generic drugs, which are bioequivalent to branded medications, have been on the rise due to their cost-effectiveness. In 2022, the demand for pharmaceutical glass packaging for generic drugs was substantial, driven by the need for safe and reliable packaging for affordable medications. This demand is expected to persist, with a steady growth rate, throughout the forecast period from 2023 to 2031.
- Branded Drugs: Branded drugs, often patented and marketed by pharmaceutical companies, require premium packaging to reflect their value and protect their integrity. The pharmaceutical glass packaging market served the branded drug segment effectively in 2022, offering a variety of high-quality packaging solutions. While the growth rate is moderate, branded drugs are expected to continue relying on glass packaging for premium presentation and product protection.
- Biologic Drugs: Biologic drugs, characterized by their complexity and sensitivity, demand specialized packaging solutions. In 2022, the Ampoules segment, known for its suitability in preserving biologics, played a significant role in the market. The rise of biologic drugs is expected to drive the demand for pharmaceutical glass packaging further, with the Ampoules segment projected to exhibit the highest CAGR during the forecast period, reflecting its critical role in ensuring the stability and efficacy of biologic medications.
APAC to Display the Highest Potential
The pharmaceutical glass packaging market exhibits distinct regional trends, with variations in growth rates and revenue distribution across different geographical areas. Asia-Pacific is expected to showcase the highest CAGR during the forecast period from 2023 to 2031, driven by the growth of pharmaceutical manufacturing in the region. North America is anticipated to retain its position as the region with the highest revenue percentage, reflecting its well-established pharmaceutical industry. Europe and Latin America are also expected to experience steady growth, as pharmaceutical companies seek to expand their presence in these regions.Market Competition to Intensify during the Forecast Period
The pharmaceutical glass packaging market is characterized by intense competition among key players, with several leading companies driving innovation and market growth. In 2022, these companies reported significant revenues and their strategies are expected to continue shaping the market from 2023 to 2031.- Gerresheimer AG: Gerresheimer AG is a prominent player in the pharmaceutical glass packaging market, known for its extensive range of glass packaging solutions. In 2022, the company reported substantial revenues, reflecting its strong market presence. Gerresheimer's key strategy centers on continuous innovation, focusing on the development of eco-friendly and premium glass packaging options.
- SCHOTT AG: SCHOTT AG specializes in glass and glass-ceramic technologies, providing high-quality pharmaceutical glass packaging solutions. In 2022, the company reported robust revenues, driven by its commitment to product quality and safety. SCHOTT AG's competitive strategy emphasizes research and development to create innovative packaging solutions, including glass materials optimized for drug stability.
- Corning Incorporated: Corning Incorporated is a renowned player in the pharmaceutical glass packaging market, offering a wide range of glass products for pharmaceutical applications. In 2022, the company reported strong revenues, reflecting its dedication to product excellence. Corning's key strategy revolves around collaboration with pharmaceutical companies to develop custom packaging solutions and ensure product compatibility.
Historical & Forecast Period
This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2023 to 2031.The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Pharmaceutical Glass Packaging market are as follows:- Research and development budgets of manufacturers and government spending
- Revenues of key companies in the market segment
- Number of end users and consumption volume, price and value.
- Geographical revenues generate by countries considered in the report
- Micro and macro environment factors that are currently influencing the Pharmaceutical Glass Packaging market and their expected impact during the forecast period.
Market Segmentation
Product
- Vials
- Small vials
- Large vials
- Bottles
- Small bottles
- Large bottles
- Cartridges & Syringes
- Ampoules
Drug Type
- Generic
- Branded
- Biologic
Region Segment (2021 - 2031; US$ Million)
- North America
- U.S.
- Canada
- Rest of North America
- UK and European Union
- UK
- Germany
- Spain
- Italy
- France
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East and Africa
- GCC
- Africa
- Rest of Middle East and Africa
Key questions answered in this report
- What are the key micro and macro environmental factors that are impacting the growth of Pharmaceutical Glass Packaging market?
- What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
- Estimated forecast and market projections up to 2031.
- Which segment accounts for the fastest CAGR during the forecast period?
- Which market segment holds a larger market share and why?
- Are low and middle-income economies investing in the Pharmaceutical Glass Packaging market?
- Which is the largest regional market for Pharmaceutical Glass Packaging market?
- What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
- Which are the key trends driving Pharmaceutical Glass Packaging market growth?
- Who are the key competitors and what are their key strategies to enhance their market presence in the Pharmaceutical Glass Packaging market worldwide?
This product will be delivered within 2 business days.
Table of Contents
1. Preface
2. Executive Summary
3. Pharmaceutical Glass Packaging Market: Competitive Analysis
4. Pharmaceutical Glass Packaging Market: Macro Analysis & Market Dynamics
5. Pharmaceutical Glass Packaging Market: By Product, 2021-2031, USD (Million)
6. Pharmaceutical Glass Packaging Market: By Drug Type, 2021-2031, USD (Million)
7. North America Pharmaceutical Glass Packaging Market, 2021-2031, USD (Million)
8. UK and European Union Pharmaceutical Glass Packaging Market, 2021-2031, USD (Million)
9. Asia Pacific Pharmaceutical Glass Packaging Market, 2021-2031, USD (Million)
10. Latin America Pharmaceutical Glass Packaging Market, 2021-2031, USD (Million)
11. Middle East and Africa Pharmaceutical Glass Packaging Market, 2021-2031, USD (Million)
12. Company Profile
List of Figures
List of Tables
Companies Mentioned
- Gerresheimer AG
- Schott AG
- Corning Incorporated
- Nipro Corporation
- SGD S.A.
- Stoelzle Oberglas GmbH
- Bormioli Pharma S.p.A.
- West Pharmaceutical Services, Inc.
- Shandong Medicinal Glass Co., Ltd.
- Beatson Clark
- Ardagh Group S.A
- Arab Pharmaceutical Glass Co.
- Piramal Enterprises Ltd.
- Sisecam Group
- Owens-Illinois, Inc.
